0
Correspondence |

Absence of Human Herpesvirus 8 in Sarcoidosis and Crohn Disease Granulomas

Keith A. Knoell, MD; John D. Hendrix, Jr, MD; Mark H. Stoler, MD; James W. Patterson, MD; Carolina M. Montes, MD
[+] Author Affiliations

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Dermatol. 2005;141(7):909-910. doi:10.1001/archderm.141.7.909-b
Text Size: A A A
Published online
Figures in this Article

Sarcoidosis and Crohn disease are chronic granulomatous conditions of unknown pathogenesis that affect multiple organ systems. A common mechanism has been proposed but never proved. Recently, it has been suggested that human herpesvirus 8 (HHV-8) might play a role in the pathogenesis of sarcoidosis based on polymerase chain reaction studies showing HHV-8 in a high proportion of affected tissues.1 We used polymerase chain reaction studies to amplify a 233–base pair fragment of HHV-8 DNA in archived specimens of tissues from patients with sarcoidosis and Crohn disease who had never been treated with corticosteroids or immunomodulator agents to determine if HHV-8 might be present in these tissues.

METHODS AND RESULTS

Archived tissue specimens from the skin of 8 patients with sarcoidosis and from the small bowel of 7 patients with Crohn disease were selected on the basis of clinical history and histopathologic findings, including the presence of granulomas. Three Kaposi sarcoma specimens and 1 primary effusion lymphoma specimen were selected as positive control tissues, and negative controls included cutaneous squamous cell carcinomas and reexcisions of normal skin from patients with dysplastic nevi.

Two pathologists (J.W.P. and M.H.S.) independently confirmed the histopathologic diagnoses. We performed tissue preparation, polymerase chain reaction, and gel fractionation on all specimens according to the method described by Gaffey et al.2 We used 50 amplification cycles. Human herpesvirus 8 DNA was not detected in affected tissues of patients with either sarcoidosis or Crohn disease. We detected HHV-8 DNA in the control samples of Kaposi sarcoma and primary effusion lymphoma but not in samples of squamous cell carcinoma or normal skin (Figure). We successfully amplified β-globulin in the Crohn disease and sarcoidosis specimens, which indicates that these specimens contained amplifiable DNA and lacked polymerase chain reaction inhibitors.

Place holder to copy figure label and caption
Figure.

Representative gel fractionation product from polymerase chain reaction amplification of a 233–base pair fragment of human herpesvirus 8 (HHV-8) DNA from various tissues. Lanes 1 and 26 are 100–pair size ladders; even lanes 2 through 24, and β-globulin amplifications; odd lanes 3 through 25, HHV-8 DNA amplifications. Lanes 22 and 23 are normal skin controls; 24 and 25, no DNA negative controls. Lanes 2 and 3 are colonic Crohn disease; 4 and 5, ileal Crohn disease; 6 and 7, mediastinal sarcoidosis; 8 and 9, cutaneous sarcoidosis; 10 through 15, cutaneous squamous cell carcinoma (1 of which failed to amplify); 16 through 19, cutaneous Kaposi sarcoma; and 20 and 21, pleural effusion lymphoma.

Grahic Jump Location

COMMENT

Human herpesvirus 8 is a novel member of the γ-herpesvirus subfamily that has been implicated in the pathogenesis of Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.1 The mechanism of HHV-8 in the induction and perpetuation of disease is not well understood; however, HHV-8 genetic homologues to human oncogenes and intercellular regulatory molecules may play a role in the pathogenesis of diseases related to the virus.

Although the cause of these granulomatous disorders has not yet been determined, it has been suspected that sarcoidosis and Crohn disease might share a common etiology based on clinical and pathologic similarities. Histologically, the 2 disorders can be virtually indistinguishable. Both diseases share common aberrations in the immune system, including altered numbers and responsiveness of T cells and dysregulation of various cytokines. Elevated serum levels of angiotensin converting enzyme are observed in the acute phase of both conditions.3

Our results argue against HHV-8 as an etiologic factor in sarcoidosis and Crohn disease. This supports findings of other investigators who have been unable to link HHV-8 infection with sarcoidosis.4 5 Although Di Alberti et al1 did detect HHV-8 in archived sarcoidosis tissues using a polymerase chain reaction method similar to ours, the reasons for the discrepancy are not entirely clear. In future investigations, confirmation by in situ hybridization or control for regional prevalence of HHV-8 may be helpful.

AUTHOR INFORMATION

Correspondence: Dr Patterson, Department of Pathology, University of Virginia, PO Box 800214, Charlottesville, VA 22908 (jwp9e@virginia.edu).

Financial Disclosure: None.

REFERENCES

Di Alberti  L, Piattelli  A, Artese  L.  et al.  Human herpesvirus 8 variants in sarcoid tissues Lancet 1997;3501655- 1661
PubMed
Gaffey  MJ, Frierson  HF, Weiss  LM, Barber  CM, Baber  GB, Stoler  MH. Human papillomavirus and Epstein-Barr virus in sinonasal Schneiderian papillomas: an in situ hybridization and polymerase chain reaction study Am J Clin Pathol 1996;106475- 482
PubMed
Familiari  G, Creperio  G, Ranzini  C, Ferrara  A. Involvement of the polypeptide system and ACE in Crohn disease Minerva Med 1987;78841- 845
PubMed
Gazouli  M, Ikonomopoulos  J, Trigidou  R, Foteinou  M, Kittas  C, Gorgoulis  V. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of greek patients with sarcoidosis J Clin Microbiol 2002;403060- 3063
PubMed
Haburchak  DR, Thomason  JW, Edelman  DC, Constantine  NT. Negative human herpesvirus 8 serology in sarcoidosis [letter] J Hum Virol 2001;4111
PubMed

First Page Preview

First page PDF preview

Figures

Place holder to copy figure label and caption
Figure.

Representative gel fractionation product from polymerase chain reaction amplification of a 233–base pair fragment of human herpesvirus 8 (HHV-8) DNA from various tissues. Lanes 1 and 26 are 100–pair size ladders; even lanes 2 through 24, and β-globulin amplifications; odd lanes 3 through 25, HHV-8 DNA amplifications. Lanes 22 and 23 are normal skin controls; 24 and 25, no DNA negative controls. Lanes 2 and 3 are colonic Crohn disease; 4 and 5, ileal Crohn disease; 6 and 7, mediastinal sarcoidosis; 8 and 9, cutaneous sarcoidosis; 10 through 15, cutaneous squamous cell carcinoma (1 of which failed to amplify); 16 through 19, cutaneous Kaposi sarcoma; and 20 and 21, pleural effusion lymphoma.

Grahic Jump Location

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Di Alberti  L, Piattelli  A, Artese  L.  et al.  Human herpesvirus 8 variants in sarcoid tissues Lancet 1997;3501655- 1661
PubMed
Gaffey  MJ, Frierson  HF, Weiss  LM, Barber  CM, Baber  GB, Stoler  MH. Human papillomavirus and Epstein-Barr virus in sinonasal Schneiderian papillomas: an in situ hybridization and polymerase chain reaction study Am J Clin Pathol 1996;106475- 482
PubMed
Familiari  G, Creperio  G, Ranzini  C, Ferrara  A. Involvement of the polypeptide system and ACE in Crohn disease Minerva Med 1987;78841- 845
PubMed
Gazouli  M, Ikonomopoulos  J, Trigidou  R, Foteinou  M, Kittas  C, Gorgoulis  V. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of greek patients with sarcoidosis J Clin Microbiol 2002;403060- 3063
PubMed
Haburchak  DR, Thomason  JW, Edelman  DC, Constantine  NT. Negative human herpesvirus 8 serology in sarcoidosis [letter] J Hum Virol 2001;4111
PubMed

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 5

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics